2025-524176-36-00招募中1 期
A study to learn about how a new nurandociguat tablet is absorbed and processed in the body compared to an old tablet and how food affects the way the new tablet is absorbed and processed in the body
适应症
试验速览
- 阶段
- 1 期
- 状态
- 招募中
- 发起方
- Bayer AG
- 入组人数
- 18
- 试验地点
- 1
研究概览
简要总结
暂无简介。
入排标准
- 年龄范围
- 18 years 至 64 years（18-64 Years）
- 接受健康志愿者
- 是
入选标准
- 未提供
排除标准
- 未提供
研究者
Therapeutic Area Head
Scientific
Bayer AG
研究点 (1)
Loading locations...
相似试验
已完成
1 期
A study to learn more about how safe nurandociguat is and how it affects the way the body processes rosuvastatin and dabigatran in healthy adultsChronic Kidney Disease2025-524178-40-00Bayer AG40
招募中
1 期
A study to learn how safe nurandociguat is when taken with sildenafil in men with arterial hypertension.Chronic Kidney Disease2025-522336-14-00Bayer AG36
已完成
1 期
A research study of a new medicine (NNC0650-0013) in healthy men2023-506134-79-00Novo Nordisk A/S60
招募中
1 期
A study to see the effect of NNC0194-0499 alone or in combination with semaglutide on blood sugar control in people living with type 1 diabetes.2024-519533-38-00Novo Nordisk A/S96
招募中
1 期
A study to find how well budoprutug (TNT119) works and how safe it is in participants with Systemic Lupus ErythematosusSystemic Lupus Erythematosus2024-520385-57-01Climb Bio Inc.11